| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.03 |
0.06 |
≤0.03 － 0.25 |
Retapamulin |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >100 |
Clindamycin (Cleocin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.12 |
0.25 |
≤0.12 － 4 |
Gentamicin (Gentamycin, Garamycin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>0.12 |
>200 |
≤0.12 － >200 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － 0.5 |
Cephalothin (Cefalotin, Keflin, Seffin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.12 － 8 |
Ofloxacin (Floxin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
0.25 |
0.5 |
≤0.25 － 2 |
Tiamulin (Tiamuline, Tiamutilin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>0.5 |
>2 |
≤0.03 － >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
1 |
2 |
0.25 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
≤2 |
≤2 |
≤2 － ? |
Mupirocin (Bactroban) |
592 |
| Staphylococcus hominis (coagulase-negative + mupirocin-susceptible + oxacillin-susceptible) |
>4 |
>4 |
4 － >4 |
Bacitracin (Baci-IM) |
592 |